Another round of drug shortage alarm

Source: pharmaceutical economic report 2016-03-11: the drug administration department of the national health and Family Planning Commission plans to implement the public consultation on the designated production of drug varieties It is required to provide feedback before March 18, which shows that the promotion of the designated production is urgent Most of the 16 varieties in the list have been produced for many years, with mature technology, obvious curative effect and clinically necessary products At a time when the national supply side reform has been promoted, and enterprises have been de producing, de stocking, de leveraging, reducing costs, and making up for shortcomings, is it not strange that they now use administrative means to implement fixed-point production? However, it's not surprising that after the national development and Reform Commission withdrew the administrative control over most of the drug prices, the drug production actually faced more severe administrative forced price reduction, second or even third price negotiation than before the drug price reform Some drugs have reached the point where it is difficult to maintain simple renewable production, most of which are clinically necessary, lack of market, poor substitutability and relative use A large quantity of medicine A lot of voices have criticized the false high of drug price Reducing drug price has become a goal of medical reform, but in fact, not all drug prices are false high, and some drug prices are normal or even false low (the price is close to or lower than the cost) There are industry analysis: now, by varieties, 20% of the drug price is inflated; by sales amount, 80% of the drug price is inflated These 80% varieties of drugs account for only 20% of the sales amount, which shows that many drugs are being forced out of the market At present, some local regulations reduce the price of all drugs by several percentage points For drugs with inflated prices, there may be no price reduction in place, but for drugs with normal or even inflated prices, it is a fatal injury Price is the aggregation of the value of a product and the embodiment of its use value It is also the most important economic factor for production, circulation and consumption It balances itself through market supply and demand Even in the planned economy period, the government has a set of policies and measures to control the price, which will not force the price to be reduced by several percentage points At present, some places may be in favor of changing the current situation of "expensive medical treatment" They think that the use of the simplest and most effective administrative measures to force the price down will soon be effective Perhaps in the short term, the price is indeed "in a good situation", but it is likely that the supply of goods in the white market will be cut off and the price in the black market will soar A media report at the end of last year pointed out that a survey of clinical drugs used in more than 40 top three hospitals in 12 cities across the country showed that there were more than 500 kinds of basic drugs determined by the state and local governments, and 342 kinds were in short supply, many of which were low-cost life-saving drugs Because one medicine is hard to find, the price of the medicine in short supply has been fried Some of them have increased dozens of times or even hundreds of times, that is to say, the obvious decline has contributed to the hidden increase Further analysis shows that pharmaceutical companies have no profit, or the profit space is compressed to only maintain simple reproduction Can they develop new products as the main symbol of expanding reproduction? In fact, the scope of virtual high or virtual low drug price is very clear: the drugs with virtual high price are basically exclusive drugs, patent drugs, imported drugs, and original research drugs that lack competition; The drugs with low prices are basically those produced by many companies and depreciated through multiple rounds of competition If the prices of drugs are considered to be inflated regardless of the specific situation, analysis and treatment, all prices must be reduced, which not only causes the prices of drugs with inflated prices to not be lowered, but also causes the production of drugs with inflated prices to not be maintained and forced to cut off supply Now the authorities have issued a new round of drug shortage warnings Although there are six medical methods in traditional Chinese medicine, such as Bian, needle, moxibustion, medicine and guide, food therapy, in today's world, medicine has become the main carrier of disease treatment Western medicine is a disease and a medicine, and non medicine is difficult to treat How to price a drug produced at a fixed point? If the price is still low, I'm afraid that no enterprise is willing to go to a fixed point Even if it is under administrative pressure or accepted for its own social responsibility, it is impossible to maintain a simple reproduction for a long time, let alone copy it to other enterprises of other products If a reasonable price is set at a fixed point, is it time to die for the bidding and second bargaining that only low price is taken? The competent department is worried that low price cannot produce high-quality drugs The author thinks it can be further understood that the decreasing price can not produce drugs with stable quality and reliable curative effect Medicine is to medicine what rice is to cooking It should be affirmed that the national health and Family Planning Commission focuses on the people's livelihood to solve the drug shortage in the way of designated production However, if 16 kinds of short drugs are designated, will there be more short drugs? How to treat both the symptoms and the symptoms in the process of administrative management? After extensive and comprehensive social investigation, it is necessary to find out the real cause of drug shortage, take effective measures directly to solve the problem fundamentally, which is the next thing that the competent department needs to promote as soon as possible.